SCOPUS 정보 검색 플랫폼

Trends in Molecular Medicine

Volumn 22, Issue 1, 2016, Pages 1-3

The Role of Prostaglandin E2 in Tumor-Associated Immunosuppression

(2) Wang, Dingzhi a DuBois, Raymond N a,b

a ARIZONA STATE UNIVERSITY (United States)

b MAYO CLINIC (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CHECKPOINT KINASE INHIBITOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; NONSTEROID ANTIINFLAMMATORY AGENT; PROGRAMMED DEATH 1 RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN INHIBITOR; T LYMPHOCYTE RECEPTOR; PROSTAGLANDIN SYNTHASE;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER IMMUNOTHERAPY; GENE DELETION; HUMAN; IMMUNE EVASION; IMMUNOSURVEILLANCE; REGULATORY T LYMPHOCYTE; RISK FACTOR; SHORT SURVEY; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; ANIMAL; IMMUNOLOGY; METABOLISM; NEOPLASM; TUMOR ESCAPE;

ANIMALS; HUMANS; NEOPLASMS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR ESCAPE;

EID: 84952777812 PISSN: 14714914 EISSN: 1471499X Source Type: Journal
DOI: 10.1016/j.molmed.2015.11.003 Document Type: Short Survey

Times cited : (86)

References (10)

1
- 64049109107
- Cyclooxygenase-2 (Cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung
- Harris R.E. Cyclooxygenase-2 (Cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology 2009, 17:55-67.
- (2009) Inflammopharmacology , vol.17 , pp. 55-67
- Harris, R.E.¹

2
- 84942292465
- Inflammation and cancer: advances and new agents
- Crusz S.M., Balkwill F.R. Inflammation and cancer: advances and new agents. Nat. Rev. Clin. Oncol. 2015, 12:584-596.
- (2015) Nat. Rev. Clin. Oncol. , vol.12 , pp. 584-596
- Crusz, S.M.¹ Balkwill, F.R.²

3
- 77649179672
- Eicosanoids and cancer
- Wang D., DuBois R.N. Eicosanoids and cancer. Nat. Rev. Cancer 2010, 10:181-193.
- (2010) Nat. Rev. Cancer , vol.10 , pp. 181-193
- Wang, D.¹ DuBois, R.N.²

4
- 84856748026
- 2 promotes intestinal tumor growth via DNA methylation
- 2 promotes intestinal tumor growth via DNA methylation. Nat. Med. 2012, 18:224-226.
- (2012) Nat. Med. , vol.18 , pp. 224-226
- Xia, D.¹

5
- 84941419767
- Cyclooxygenase-dependent tumor growth through evasion of immunity
- Zelenay S., et al. Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell 2015, 162:1257-1270.
- (2015) Cell , vol.162 , pp. 1257-1270
- Zelenay, S.¹

6
- 84900471198
- Peroxisome proliferator-activated receptor delta promotes colonic inflammation and tumor growth
- Wang D., et al. Peroxisome proliferator-activated receptor delta promotes colonic inflammation and tumor growth. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:7084-7089.
- (2014) Proc. Natl. Acad. Sci. U.S.A. , vol.111 , pp. 7084-7089
- Wang, D.¹

7
- 84889023629
- An inflammatory mediator, prostaglandin E2, in colorectal cancer
- Wang D., DuBois R.N. An inflammatory mediator, prostaglandin E2, in colorectal cancer. Cancer J. 2013, 19:502-510.
- (2013) Cancer J. , vol.19 , pp. 502-510
- Wang, D.¹ DuBois, R.N.²

8
- 84943737064
- Immunosuppression associated with chronic inflammation in the tumor microenvironment
- Wang D., DuBois R.N. Immunosuppression associated with chronic inflammation in the tumor microenvironment. Carcinogenesis 2015, 36:1085-1093.
- (2015) Carcinogenesis , vol.36 , pp. 1085-1093
- Wang, D.¹ DuBois, R.N.²

9
- 84892365940
- Checkpoint blocking antibodies in cancer immunotherapy
- Kyi C., Postow M.A. Checkpoint blocking antibodies in cancer immunotherapy. FEBS Lett. 2014, 588:368-376.
- (2014) FEBS Lett. , vol.588 , pp. 368-376
- Kyi, C.¹ Postow, M.A.²

10
- 84901334642
- Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy
- Highfill S.L., et al. Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy. Sci. Transl. Med. 2014, 6:237ra267.
- (2014) Sci. Transl. Med. , vol.6 , pp. 237ra267
- Highfill, S.L.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.